乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

CROI

<乌鸦传媒>Severe Mpox in Advanced HIV Patients Tied to Complications, Death

Researchers argue that severe mpox is AIDS-defining; critics say that's stigmatizing

<乌鸦传媒>Higher Dose of Ivermectin, and for Longer, Still No Help Against COVID

Losing streak continues for controversial antiparasitic

<乌鸦传媒>Children's HIV Deaths in Africa Largely Preventable

Half of kids under age 5 not diagnosed before death, CHAMPS study found

<乌鸦传媒>Investigational Oral Antiviral Shows Promise in COVID Outpatients

Exploratory analyses also point to possible reduction in long COVID symptoms

<乌鸦传媒>COVID Rebound Not Exclusive to Those on Paxlovid

However, these rebound cases were rare and lasted only about 1 day

<乌鸦传媒>Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Substudy of HPTN 083 trial examined differences in outcomes by race among U.S. participants

<乌鸦传媒>Doxycycline Fails to Protect Women Against STIs

Trial results came as a surprise after success in prophylaxis for other groups

<乌鸦传媒>Sutezolid With 3-Drug Combo Appears Safe and Effective in Multidrug-Resistant TB

Sutezolid may be a replacement for linezolid in these patients, researcher says

<乌鸦传媒>TB Treatment Strategy Has Potential to Drastically Slash Therapy Duration

8-week regimen, with more for persistent cases, yields similar outcomes to 6-month standard

<乌鸦传媒>HIV Self-Tests Reached High-Risk Populations

CDC researchers found a substantial minority of patients had never been tested

<乌鸦传媒>Ablating High-Grade Anal Lesions Thwarts Progression to Cancer

Screening followed by aggressive therapy shows benefit in phase III ANCHOR study

<乌鸦传媒>Injectable Sotrovimab Offers Another Route for COVID Treatment

Intramuscular version of monoclonal antibody on par with infusion

<乌鸦传媒>COVID Makes Everything Worse in Pregnancy

And those with HIV experienced the worst outcomes

<乌鸦传媒>Young Women Prefer Vaginal Ring as HIV Prevention

But oral pre-exposure prophylaxis also gets support, study in Africa finds

<乌鸦传媒>Fewer Pills Plus Shorter Time: New Way to Control Drug-Resistant TB?

Randomized trial looks at three investigational regimens versus standard of care

<乌鸦传媒>Universal HCV Screening in Pregnancy Boosts Detection

More cases found verses risk-based approach, also IDs perinatal transmission, researcher says

<乌鸦传媒>ART-Free Strategy Could Control HIV in Some African Kids

Broadly neutralizing antibodies show promise in proof-of-concept study in Botswana

<乌鸦传媒>Third Person 'Cured' of HIV via Transplant

U.S. woman with leukemia gets cord blood resistant to HIV

<乌鸦传媒>Novel Strategy Slashes HBV Vertical Transmission Sans Immunoglobulin

Cambodian study finds antenatal antiviral effective if used for long enough

<乌鸦传媒>U.S. Sees Drop in Lifetime Risk of HIV Diagnosis

One of every 120 Americans will be diagnosed with HIV in their lifetime, analysis suggests

<乌鸦传媒>Healers Lend a Hand to HIV Testing in Rural Uganda

Modern medicine benefits from engaging with local traditions

<乌鸦传媒>Could One mRNA COVID Shot Be Adequate for Past Infectees?

Small study shows powerful antibody response after first dose

<乌鸦传媒>Novel Drug Dents Super-Refractory HIV Infection

"I was blown away by these results," said press conference moderator

<乌鸦传媒>Therapeutic HIV Vax Trial Takes Its First-in-Human Steps

But long way from a true functional cure

<乌鸦传媒>Pediatric HIV: Trial Sets Tivicay Backbone as Best First-Line Option

And "at least non-inferior" in second line

<乌鸦传媒>HIV, High-Risk Pregnancy and Coronavirus

Outcomes support case for pregnant women to be vaccinated against COVID-19

<乌鸦传媒>Maturation Inhibitor Shows Promise for HIV

Encouragement from phase II study, but emergent resistance remains a problem

<乌鸦传媒>Do HIV Drug Trials Need Better Infection Tests?

Data from PrEP study reveal a sensitivity problem

<乌鸦传媒>Dramatic Increase Seen in Getting HIV Patients Into Treatment

Percentage of newly diagnosed individuals receiving "timely" therapy doubled in past decade

<乌鸦传媒>'Amazon Prime'-Type ART Delivery Worked for South African HIV Patients

More experienced viral suppression versus traditional clinic visits

<乌鸦传媒>PrEP Implant May Protect Against HIV for a Year

Early study paves way for clinical trial

<乌鸦传媒>Good News, Bad News in HIV Prevention Research

HVTN vaccine trial failed, but phase I antibody trial showed promise

<乌鸦传媒>HIV+ Adults Living Longer, but Not Healthier Lives

Fewer comorbidity-free years versus those without HIV, even among those starting ART early

<乌鸦传媒>Attack on HIV Reservoir Falls Short

No impact seen with romidepsin and neutralizing antibody agent

<乌鸦传媒>Birth Control Implants, HIV Meds Safe Together

Drug-drug interactions not seen in combination

<乌鸦传媒>West Virginia HIV Outbreak: A Blueprint for Public Health Response

Used four pillars of federal initiative to manage local HIV epidemic

<乌鸦传媒>After 30 Months, 'London Patient' Still in HIV Remission

Longer-term findings encouraging in blood, semen, and other HIV reservoir sites

<乌鸦传媒>What's Behind London's Falling HCV Rates in HIV+ MSM?

City cut HCV incidence in this population by almost 70% in 5 years

<乌鸦传媒>Monthly HIV Treatment on Par With Daily Regimen

High percentage of patients maintain undetectable viral loads

<乌鸦传媒>Integrase Inhibitors Drop Virus Faster in Pregnant HIV Patients

Raltegravir, dolutegravir both appear safe and effective in late stage pregnancy

1